{
  "id": "_b2223",
  "type": "EvidenceLine",
  "evidenceItem": [
    {
      "id": "_b3473",
      "type": "CriterionAssessment",
      "criterion": {
        "id": "SEPIO-CG:99025",
        "type": "Criterion",
        "label": "PS3",
        "description": "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product",
        "defaultStrength": {
          "id": "SEPIO:0000330",
          "type": "EvidenceLineStrength",
          "label": "Pathogenic Strong"
        },
        "comments": "This particular rule will probably be downgraded often, given that there are not many “Functional studies that have been validated and shown to be reproducible and robust in a clinical diagnostic laboratory setting”"
      },
      "variant": {
        "id": "CAR:CA090930",
        "type": "CanonicalAllele",
        "preferredCtxAllele": {
          "id": "_b229",
          "type": "ContextualAllele",
          "relatedCanonicalAllele": "CanAll124",
          "alleleName": "NM_005633.3(SOS1):c.1010A>G (p.Tyr337Cys)"
        }
      },
      "outcome": {
        "id": "SEPIO:0000223",
        "type": "CriterionEvaluation",
        "label": "Met"
      },
      "evidenceLine": [
        {
          "id": "_b2215",
          "type": "EvidenceLine",
          "evidenceItem": [
            {
              "id": "_b3166",
              "type": "AlleleFunctionalImpact",
              "resultDescription": "increased ERK activtation",
              "assayType": {
                "id": "OBI:XXXXXX1",
                "type": "AlleleFunctionalAssayMethod",
                "label": "Activation Assay"
              },
              "contextualAllele": {
                "id": "_b229",
                "type": "ContextualAllele",
                "relatedCanonicalAllele": "CanAll124",
                "alleleName": "NM_005633.3(SOS1):c.1010A>G (p.Tyr337Cys)"
              },
              "gene": {
                "id": "HGNC:11187",
                "type": "Gene",
                "geneSymbol": "SOS1"
              },
              "description": "PMID: 23487764"
            }
          ]
        }
      ],
      "contribution": [
        {
          "type": "Contribution",
          "agent": {
            "id": "Agent007",
            "type": "Agent",
            "label": "Stefan DiMarino"
          },
          "contributionDate": "3/14/2017 10:29 AM",
          "contributionRole": {
            "id": "SEPIO:0000154",
            "type": "ContributoryRole",
            "label": "assessor role"
          }
        }
      ],
      "description": "Flag-tagged construct with the variant was transfected into HEK cells. As per the RASopathy working group’s approved assays (see example 3 above), Smith et al. showed that the Y337C mutation increased levels of pERK in starved HEK cells via western blotting."
    }
  ],
  "evidenceStrength": {
    "id": "SEPIO:0000330",
    "type": "EvidenceLineStrength",
    "label": "Pathogenic Strong"
  },
  "contribution": [
    {
      "type": "Contribution",
      "agent": {
        "id": "Agent007",
        "type": "Agent",
        "label": "Stefan DiMarino"
      },
      "contributionDate": "3/14/2017 10:29 AM",
      "contributionRole": {
        "id": "SEPIO:0000154",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    }
  ],
  "@context": "http://datamodel.clinicalgenome.org/interpretation/json/context"
}
